Cadent Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Cadent Capital Advisors's AMGN Position: Q2 2026 in Review
Cadent Capital Advisors increased its Amgen (AMGN) stake by 0.72% in Q2 2026, buying an estimated $2.74K and bringing the position to 1,117 shares worth $404K. The position accounts for 0.08% of the portfolio, ranked #134.
Cadent Capital Advisors first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cadent Capital Advisors held 1,117 shares of Amgen worth $404K as of Q2 2026.
- Cadent Capital Advisors bought 8 Amgen shares in Q2 2026, an estimated $2.74K.
- Amgen made up 0.08% of Cadent Capital Advisors's portfolio in Q2 2026, its #134 holding.
- Cadent Capital Advisors first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.